{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:53:31Z","timestamp":1791543211598,"version":"4.3.4"},"reference-count":55,"publisher":"Rockefeller University Press","issue":"6","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,6,3]]},"abstract":"<jats:p>Fibroblast activation protein-\u03b1 (FAP) identifies stromal cells of mesenchymal origin in human cancers and chronic inflammatory lesions. In mouse models of cancer, they have been shown to be immune suppressive, but studies of their occurrence and function in normal tissues have been limited. With a transgenic mouse line permitting the bioluminescent imaging of FAP+ cells, we find that they reside in most tissues of the adult mouse. FAP+ cells from three sites, skeletal muscle, adipose tissue, and pancreas, have highly similar transcriptomes, suggesting a shared lineage. FAP+ cells of skeletal muscle are the major local source of follistatin, and in bone marrow they express Cxcl12 and KitL. Experimental ablation of these cells causes loss of muscle mass and a reduction of B-lymphopoiesis and erythropoiesis, revealing their essential functions in maintaining normal muscle mass and hematopoiesis, respectively. Remarkably, these cells are altered at these sites in transplantable and spontaneous mouse models of cancer-induced cachexia and anemia. Thus, the FAP+ stromal cell may have roles in two adverse consequences of cancer: their acquisition by tumors may cause failure of immunosurveillance, and their alteration in normal tissues contributes to the paraneoplastic syndromes of cachexia and anemia.<\/jats:p>","DOI":"10.1084\/jem.20122344","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T21:00:41Z","timestamp":1369688441000},"page":"1137-1151","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":394,"title":["Depletion of stromal cells expressing fibroblast activation protein-\u03b1 from skeletal muscle and bone marrow results in cachexia and anemia"],"prefix":"10.1084","volume":"210","author":[{"given":"Edward W.","family":"Roberts","sequence":"first","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Deonarine","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice E.","family":"Denton","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Feig","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K.","family":"Lyons","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Espeli","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kraman","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"McKenna","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.B.","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Ludwig Collaborative Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD 21231 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavia L.","family":"Caballero","sequence":"additional","affiliation":[{"name":"Ludwig Collaborative Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD 21231 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Larder","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Coll","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O\u2019Rahilly","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Brindle","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Teichmann","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Tuveson","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas T.","family":"Fearon","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Department of Medicine 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cambridge Institute for Medical Research, Wellcome Trust\/Medical Research Council (MRC) Building 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Institute of Metabolic Sciences; Addenbrooke\u2019s Hospital 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre 1 ; 2 ; and 3 ; 4 ; and 5"},{"name":"MRC Laboratory of Molecular Biology; University of Cambridge, Cambridge CB2 2QH, England, UK 1 ; 2 ; and 3 ; 4 ; and 5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2013,5,27]]},"reference":[{"key":"2023072601581723900_bib1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccr.2005.10.004","article-title":"Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia","volume":"8","author":"Acharyya","year":"2005","journal-title":"Cancer Cell."},{"key":"2023072601581723900_bib2","doi-asserted-by":"publisher","first-page":"19441","DOI":"10.1074\/jbc.C500092200","article-title":"Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha","volume":"280","author":"Aertgeerts","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2023072601581723900_bib3","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar2080","article-title":"Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes","volume":"8","author":"Bauer","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"2023072601581723900_bib4","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2023072601581723900_bib5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science."},{"key":"2023072601581723900_bib6","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","article-title":"Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata","volume":"32","author":"Brokopp","year":"2011","journal-title":"Eur. Heart J."},{"key":"2023072601581723900_bib7","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/oby.2011.97","article-title":"Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis","volume":"19","author":"Brown","year":"2011","journal-title":"Obesity (Silver Spring)."},{"key":"2023072601581723900_bib8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/hmg\/ddq499","article-title":"Proteasome inhibition improves the muscle of laminin \u03b12 chain-deficient mice","volume":"20","author":"Carmignac","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"2023072601581723900_bib9","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1073\/pnas.162488599","article-title":"Diversity, topographic differentiation, and positional memory in human fibroblasts","volume":"99","author":"Chang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072601581723900_bib10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2007.04.001","article-title":"The hormonal control of food intake","volume":"129","author":"Coll","year":"2007","journal-title":"Cell."},{"key":"2023072601581723900_bib11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"2023072601581723900_bib12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding","year":"2012","journal-title":"Nature."},{"key":"2023072601581723900_bib13","first-page":"10","article-title":"Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin","volume":"5","author":"Dolznig","year":"2005","journal-title":"Cancer Immun."},{"key":"2023072601581723900_bib14","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"2023072601581723900_bib15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.clon.2009.04.007","article-title":"Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer","volume":"21","author":"Eager","year":"2009","journal-title":"Clin. Oncol. (R. Coll. Radiol.)."},{"key":"2023072601581723900_bib16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1471-2407-9-263","article-title":"Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma","volume":"9","author":"Eager","year":"2009","journal-title":"BMC Cancer."},{"key":"2023072601581723900_bib17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"2023072601581723900_bib18","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072601581723900_bib19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/MCO.0b013e32833862df","article-title":"Signaling pathways perturbing muscle mass","volume":"13","author":"Glass","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"2023072601581723900_bib20","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072601581723900_bib21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/msb.2011.28","article-title":"RNA sequencing reveals two major classes of gene expression levels in metazoan cells","volume":"7","author":"Hebenstreit","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"2023072601581723900_bib22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ceb.2012.03.007","article-title":"Duel of the fates: the role of transcriptional circuits and noise in CD4+ cells","volume":"24","author":"Hebenstreit","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"2023072601581723900_bib23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell."},{"key":"2023072601581723900_bib24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000069863","article-title":"Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer","volume":"26","author":"Hofheinz","year":"2003","journal-title":"Onkologie."},{"key":"2023072601581723900_bib25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/1061186X.2010.511225","article-title":"Evaluation of the tumor targeting of a FAP\u03b1-based doxorubicin prodrug","volume":"19","author":"Huang","year":"2011","journal-title":"J. Drug Target."},{"key":"2023072601581723900_bib26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1098\/rspb.1950.0065","article-title":"The hypothalamic control of food intake in rats","volume":"137","author":"Kennedy","year":"1950","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"2023072601581723900_bib27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science."},{"key":"2023072601581723900_bib28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods."},{"key":"2023072601581723900_bib29","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/1535-7163.MCT-08-1170","article-title":"Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin","volume":"8","author":"LeBeau","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"2023072601581723900_bib30","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072601581723900_bib31","doi-asserted-by":"publisher","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072601581723900_bib32","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/me.2010-0127","article-title":"Regulation of muscle mass by follistatin and activins","volume":"24","author":"Lee","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"2023072601581723900_bib33","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/hep.510290631","article-title":"Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis","volume":"29","author":"Levy","year":"1999","journal-title":"Hepatology."},{"key":"2023072601581723900_bib34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s001090000137","article-title":"Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites","volume":"78","author":"Mantovani","year":"2000","journal-title":"J. Mol. Med."},{"key":"2023072601581723900_bib35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.9.2.493","article-title":"Satellite cell of skeletal muscle fibers","volume":"9","author":"Mauro","year":"1961","journal-title":"J. Biophys. Biochem. Cytol."},{"key":"2023072601581723900_bib36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcp.20757","article-title":"Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism","volume":"209","author":"McFarlane","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"2023072601581723900_bib37","doi-asserted-by":"publisher","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","article-title":"Double muscling in cattle due to mutations in the myostatin gene","volume":"94","author":"McPherron","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072601581723900_bib38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/MCB.20.3.1089-1094.2000","article-title":"Targeted disruption of mouse fibroblast activation protein","volume":"20","author":"Niedermeyer","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2023072601581723900_bib39","first-page":"445","article-title":"Expression of the fibroblast activation protein during mouse embryo development","volume":"45","author":"Niedermeyer","year":"2001","journal-title":"Int. J. Dev. Biol."},{"key":"2023072601581723900_bib40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.immuni.2010.08.017","article-title":"The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche","volume":"33","author":"Omatsu","year":"2010","journal-title":"Immunity."},{"key":"2023072601581723900_bib41","doi-asserted-by":"publisher","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","article-title":"Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts","volume":"274","author":"Park","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2023072601581723900_bib42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","article-title":"The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts","volume":"21","author":"Peinado","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"2023072601581723900_bib43","first-page":"6406","article-title":"Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets","volume":"46","author":"Rettig","year":"1986","journal-title":"Cancer Res."},{"key":"2023072601581723900_bib44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell."},{"key":"2023072601581723900_bib45","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1172\/JCI38988","article-title":"Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice","volume":"119","author":"Santos","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2023072601581723900_bib46","first-page":"1639","article-title":"A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer","volume":"9","author":"Scott","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"2023072601581723900_bib47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrc1648","article-title":"The anaemia of cancer: death by a thousand cuts","volume":"5","author":"Spivak","year":"2005","journal-title":"Nat. Rev. Cancer."},{"key":"2023072601581723900_bib48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nbt957","article-title":"Correction of multi-gene deficiency in vivo using a single \u2018self-cleaving\u2019 2A peptide-based retroviral vector","volume":"22","author":"Szymczak","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"2023072601581723900_bib49","first-page":"2290","article-title":"Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice","volume":"50","author":"Tanaka","year":"1990","journal-title":"Cancer Res."},{"key":"2023072601581723900_bib50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"2023072601581723900_bib51","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"2023072601581723900_bib52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.immuni.2011.08.007","article-title":"Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types","volume":"35","author":"Wei","year":"2011","journal-title":"Immunity."},{"key":"2023072601581723900_bib53","first-page":"18","article-title":"A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia","volume":"6","author":"Wiedenmann","year":"2008","journal-title":"J. Support. Oncol."},{"key":"2023072601581723900_bib54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell."},{"key":"2023072601581723900_bib55","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/210\/6\/1137\/1748940\/jem_20122344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/210\/6\/1137\/1748940\/jem_20122344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T21:59:08Z","timestamp":1690322348000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/210\/6\/1137\/41521\/Depletion-of-stromal-cells-expressing-fibroblast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,27]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6,3]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20122344","relation":{},"ISSN":["1540-9538","0022-1007"],"issn-type":[{"value":"1540-9538","type":"electronic"},{"value":"0022-1007","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5,27]]}}}